UMIN ID: UMIN000001759
Registered date:01/07/2009
Double blind, randomized Placebo-controlled study for FD
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | functional dyspepsia |
| Date of first enrollment | 2010/06/01 |
| Target sample size | 200 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | anti-secretory drug placebo |
Outcome(s)
| Primary Outcome | Severity of dyspeptic symptoms by symptomatic scale and GSRS |
|---|---|
| Secondary Outcome | Patients' background anti-H. pylori IgG |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Patients with organic disease |
Related Information
| Primary Sponsor | Office of the ELF study |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Donation |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Naoki Tomotsugu, Ph.D. |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan Japan |
| Telephone | 03-5363-3288 |
| naokit@sc.itc.keio.ac.jp | |
| Affiliation | Keio University School of Medicine Center for Clinical Research |
| scientific contact | |
| Name | Hidekazu Suzuki, M.D., Ph.D. |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan Japan |
| Telephone | 03-5363-3914 |
| Affiliation | Keio University School of Medicine Division of Gastroenterology and Hepatology, Department of Internal Medicine |